- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/88 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using liposome vesicle
Patent holdings for IPC class C12N 15/88
Total number of patents in this class: 2044
10-year publication summary
59
|
69
|
91
|
115
|
124
|
111
|
130
|
221
|
297
|
277
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Modernatx, Inc. | 1284 |
83 |
Translate bio, Inc. | 416 |
56 |
The Regents of the University of California | 20059 |
40 |
The Johns Hopkins University | 5709 |
36 |
Massachusetts Institute of Technology | 10102 |
35 |
BioNTech SE | 685 |
31 |
The University of British Columbia | 1508 |
30 |
Flagship Pioneering Innovations V, Inc. | 222 |
23 |
Arbutus Biopharma Corporation | 177 |
21 |
Intellia Therapeutics, Inc. | 211 |
21 |
Board of Regents, The University of Texas System | 5849 |
20 |
Life Technologies Corporation | 3320 |
20 |
NanoVation Therapeutics Inc. | 65 |
20 |
The Trustees of the University of Pennsylvania | 4337 |
18 |
Generation Bio Co. | 147 |
16 |
Alnylam Pharmaceuticals, Inc. | 1142 |
15 |
Ramot at Tel-Aviv University Ltd. | 1486 |
15 |
Molecular Transfer, Inc. | 31 |
14 |
National University Corporation Hokkaido University | 1345 |
14 |
Ohio State Innovation Foundation | 2166 |
14 |
Other owners | 1502 |